Clinical Trial Update: Established Status Epilepticus Treatment Trial [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating treatment for benzodiazepine-refractory status epilepticus has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benzodiazepine-refractory Status Epilepticus
• Status Epilepticus

Snippet

Sponsor: University of Virginia | Conditions: Benzodiazepine Refractory Status Epilepticus | Phase 3 | Status: COMPLETED | Results posted: 2020-02-28